Publications

Included here is a list of publications from OCG programs. All published data are available to the research community through the program-specific data matrices.

* denotes publications from the CTD² initiative that are results of intra-Network collaborations

CTD²

October 01, 2021

KITlow Cells Mediate Imatinib Resistance in Gastrointestinal Stromal Tumor.

Molecular Cancer Therapeutics

CTD²

September 08, 2021

A time-resolved fluorescence resonance energy transfer screening assay for discovery of protein-protein interaction modulators

STAR Protocols

CTD²

August 23, 2021

Pan-cancer analysis of pathway-based gene expression pattern at the individual level reveals biomarkers of clinical prognosis

Cell Reports Methods

CTD²

July 27, 2021

SMAD4 represses FOSL1 expression and pancreatic cancer metastatic colonization

Cell Reports

CTD²

July 22, 2021

Discovery of the first chemical tools to regulate MKK3-mediated MYC activation in cancer

Bioorganic & Medicinal Chemistry

CTD²

July 20, 2021

Uncoupling of gene expression from copy number presents therapeutic opportunities in aneuploid cancers

Cell Reports Medicine

CTD²

July 14, 2021

Haplotype-resolved germline and somatic alterations in renal medullary carcinomas

Genome Medicine

CTD²

July 13, 2021

Targeting KRAS4A splicing through the RBM39/DCAF15 pathway inhibits cancer stem cells

Nat Communications

CTD²

June 01, 2021

Deep immune profiling reveals targetable mechanisms of immune evasion in immune checkpoint inhibitor-refractory glioblastoma

Journal for ImmunoTherapy of Cancer

CTD²

June 01, 2021

A CRISPR/Cas9-Engineered ARID1A-Deficient Human Gastric Cancer Organoid Model Reveals Essential and Nonessential Modes of Oncogenic Transformation*

Cancer Discovery

Publications

Pages